<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000488.v1.p1" parentStudy="phs000488.v1.p1" createDate="2012-04-04" modDate="2012-09-17">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Matthew Meyerson, MD, PhD</td><td>Broad Institute, Cambridge MA, Dana Farber Cancer Institute, Boston MA, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Stacey Gabriel, PhD</td><td>Broad Institute, Cambridge MA, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Eric Lander, PhD</td><td>Broad Institute, Cambridge MA, USA</td></tr>
		<tr><td>Funding Source</td><td>U54HG003067</td><td>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Genomic Sequencing of Lung Adenocarcinoma</StudyNameEntrez>
	<StudyNameReportPage>Genomic Sequencing of Lung Adenocarcinoma</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Lung carcinoma is the leading cause of cancer death in the United States and world-wide; lung adenocarcinoma is the most common cause of lung cancer. Pilot studies of lung adenocarcinoma with hybrid-capture based whole exome sequencing will enable us to identify new targets for therapy and improve diagnosis. We will analyze a blend of whole exome and whole genome sequencing data as well as copy number and somatic mutation calls for 200 tumor and matched normal controls. When completed this study will represent the most comprehensive lung adenocarcinoma genome dataset to date.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p> N/A </p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Carcinoma, Non-Small-Cell Lung"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Matthew Meyerson, MD, PhD</AttName>
			<Institution>Broad Institute, Cambridge MA, Dana Farber Cancer Institute, Boston MA, USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Stacey Gabriel, PhD</AttName>
			<Institution>Broad Institute, Cambridge MA, USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Eric Lander, PhD</AttName>
			<Institution>Broad Institute, Cambridge MA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>U54HG003067</AttName>
			<Institution>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
		<ConsentGroup groupNum="2" shortName="CRO" longName="Cancer Research Only"/>
		<ConsentGroup groupNum="3" shortName="LCO" longName="Lung Cancer Only"/>
		<ConsentGroup groupNum="4" shortName="CRMO" longName="Cancer and Methods Research Only"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHGRI</DacName>
      <DacFullName>National Human Genome Research Institute</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000488.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000488.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000488.v1.p1" FileName="LANDER_Lung_Adenocarcinoma_Tumo_Exome_Sequencing_ProjectFinal.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>General Research Use</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="3">
        <ConsentName>Lung Cancer Only</ConsentName>
        <ConsentAbbrev>LCO</ConsentAbbrev>
        <UseLimitation>The research must be directly concerned with aspects of lung cancer</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="4">
        <ConsentName>Cancer and Methods Research Only</ConsentName>
        <ConsentAbbrev>CRMO</ConsentAbbrev>
        <UseLimitation>Cancer and Methods Research Only</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="2">
        <ConsentName>Cancer Research Only</ConsentName>
        <ConsentAbbrev>CRO</ConsentAbbrev>
        <UseLimitation>Cancer Research Only</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
